BOSTON--Elucid has announced that Noridian will extend coverage for AI-enabled quantitative coronary plaque analysis, including its FDA-cleared PlaqueIQ™ image analysis software, beginning December 8, ...

Breast arterial calcifications can appear on these screenings, but it's unclear whether they're a reliable gauge for ...

It pointed to 2018 – that’s pre-COVID-19 pandemic – data from the Centers for Disease Control and Prevention (CDC ... and the ...

When people check in for their annual mammogram these days, some may face a surprising question: In addition to reviewing the ...

The following is a summary of “Multivessel revascularization in non-ST segment elevation acute coronary syndromes: A ...

After receiving a green light earlier this year from the FDA, Medtronic has now collected a European approval for the latest ...

Manhasset, N.Y.-based North Shore University Hospital had the lowest 30-day mortality rate for coronary artery bypass graft patients in the U.S. between July 1, 2020, and June 30, 2023, according to ...

Medtronic has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to ...

Early onset coronary artery disease (CAD) in individuals under 45 years old presents unique challenges, with prevalence rates of 1-2% generally, and as high as 5-10% among South Asian populations.

Medtronic (NYSE: MDT) announced today that it received FDA investigational device exemption (IDE) for its Prevail drug-coated ...

Coronary artery disease is the silent killer because you can have it for years and have no symptoms until it’s too late.

A silent heart attack often goes unnoticed, posing serious health risks. Understand symptoms, risk factors, and prevention strategies for better heart health.